GNLX vs STE · rev $8.0K vs P/E 25, rev $5.94B
Genelux Corporation Common Stock (GNLX) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Genelux Corporation Common Stock (GNLX) is a biotechnology company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported GNLX revenue for 2025-12-31 was $8.0K. Net income was -$32.1M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. GNLX currently screens at market cap $130.6M.
Latest reported STE revenue for 2026-03-31 was $5.94B. Net income was $782.3M. Revenue was up 8.7% from 2025-03-31 to 2026-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
GNLX currently screens at market cap $130.6M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the GNLX and STE stock pages for the full models.
Not investment advice.